The Archer® VariantPlex® Comprehensive Thyroid and Lung (CTL) kit is an NGS-based targeted sequencing assay to detect CNVs, SNVs and indels in 31 thyroid and lung cancer-implicated genes. The kit covers entire targeted exons while maintaining high coverage uniformity (> 95%) and on-target reads (99.9%).
Lung Cancer, Thyroid Gland Carcinoma
AKT1 (V-akt murine thymoma viral oncogene homolog 1), ALK (Anaplastic lymphoma kinase), BRAF (B-raf proto-oncogene), CCND1 (Cyclin D1), CTNNB1 (Catenin (cadherin-associated protein), beta 1), DDR2 (Discoidin domain receptor 2)
See More ...
Next-Generation Sequencing (NGS)